<DOC>
	<DOCNO>NCT02372344</DOCNO>
	<brief_summary>The purpose study assess effect food timing pharmacokinetics ( PK ) AZD0585 effect food time tolerability safety AZD0585 healthy male Japanese subject .</brief_summary>
	<brief_title>A Study Investigate Effect Food Pharmacokinetics Total EPA Total DHA AZD0585 Healthy Male Japanese Subjects</brief_title>
	<detailed_description>This study open-label , randomize , cross-over design three single-dose treatment period washout least 10 day treatment visit . The study period consist 5 visit study centre : Visit 1 ( enrolment ) , Visit 2 ( first single-dose treatment ) , Visit 3 ( second single-dose treatment ) , Visit 4 ( third single-dose treatment ) Visit 5 ( follow-up ) . Target subject population healthy male Japanese subject age 20-45 year . Following overnight fast least 10 hour , single dose 4 g AZD0585 administer 3 separate occasion ( fast , meal , meal ) randomize crossover fashion different food restriction .</detailed_description>
	<criteria>Healthy Japanese male , 20 45 year age ( inclusive ) . Body mass index ( BMI ) ≥ 18.5 ≤ 25 ( kg/m2 ) . Medically healthy clinically insignificant screen result ( e.g. , laboratory profile , medical history , ECGs , physical finding ) . Hemoglobin level must ≥ low limit study centre reference range . 12Lead ECG QT interval correct heart rate use Fridericia 's formula ( QTcF ) &gt; 340 msec &lt; 450 msec . No habitual use drug ( ) tobacco/nicotinecontaining product minimum 3 month prior first dose . Subjects must willing able give write informed consent sign Institutional Review Board ( IRB ) approve Informed Consent Form prior admission study follow restriction procedure outline study . Past history psychological physical disorder may affect objective study , opinion PI . An individual abnormal laboratory value ( ie , suggest hepatic , renal , cardiovascular endocrine disorder diabetes mellitus ) , inappropriate current past medical history participation base decision PI . A history presence significant cardiovascular , pulmonary , hepatic , renal , haematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic psychiatric disease . Had use fish oil , EPA and/or DHAcontaining supplement within 2 month prior first admission day . Have serum ( plasma ) EPA and/or DHA concentration exceed upper limit reference range `` fatty acid profile , fourfraction '' test , determine Visit 1 .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>effect food timing PK</keyword>
	<keyword>effect food time Safety Tolerability</keyword>
	<keyword>AZD0585</keyword>
	<keyword>Japanese</keyword>
</DOC>